RASAGILINE TARTRATE API

Medichem S.A. offers wide range of pharmaceutical APIs which includes Mexiletine HCl. Indication: Ventricular arrhythmias. Contact us for more information.

Medichem S.A. offers wide range of pharmaceutical APIs which includes mirtazapine.  Indication: Treatment of major depressive disorder (MDD). Contact us for more information.

Medichem S.A. offers wide range of pharmaceutical APIs which includes Olopatadine HCl. Indication: Allergic conjunctivitis (Ophthalmic). Contact us for more information.

 Medichem S.A. offers wide range of pharmaceutical APIs which includes Nepafenac (Sterile & Non Sterile). Indication: Ophthalmic Nonsteroidal Anti-inflammatory Drug (NSAID). Contact us for more information.

Medichem S.A. offers wide range of pharmaceutical APIs which includes Paroxetine HCl. Indication: Treatment of major depressive disorder. Contact us for more information.

Medichem S.A. offers wide range of pharmaceutical APIs which includes Quetiapine Fumarate. Indication: Depressive episodes associated with bipolar disorder. Contact us for more information.

idiopathic Parkinson’s disease  API

Medichem S.A. offers wide range of pharmaceutical API which includes Saxagliptin HCl. Therapeutic: Antidiabetic. Indication: Type 2 diabetes mellitus. Contact us for more information.

Medichem S.A. offers wide range of pharmaceutical APIs which includes Solifenacin Succinate. Indication: Overactive bladder. Contact us for more information.

Medichem S.A. offers wide range of pharmaceutical APIs which includes Sunitinib Malate. Indication: Gastrointestinal stromal tumor, pancreatic tumors and renal carcinoma. Contact us for more information.

Medichem S.A. offers a wide range of pharmaceutical APIs which includes Venlafaxine HCl. Indication: Major depressive disorder (MDD). Contact us for more information.

Medichem S.A. offers wide range of pharmaceutical APIs which includes Vildagliptin. Indication: Type 2 diabetes mellitus. Contact us for more information.

COVID-19 pandemic has exposed weaknesses and sector faces new challenges driven by rising costs of production in China